icotec Receives FDA Clearance for CMORE CT System, Expanding BlackArmor Carbon-PEEK Technology to Cervicothoracic Spine
Key Insights
icotec (search) announced FDA clearance for its CMORE CT system (search), marking the first spinal implants made of nonmetallic and radiolucent BlackArmor technology for posterior cervicothoracic spine (search) stabilization.
The system features BlackArmor Engineered Carbon/PEEK (search) composite material with interwoven 3D fiber architecture that provides radiolucent imaging across MRI, CT, and X-ray modalities.
The technology enables comprehensive treatment modalities in adjuvant tumor therapy and enhances postoperative imaging diagnostics for patients with spinal tumors (search), infections, and complex pathologies.
icotec (search), the pioneer of implantable devices made from BlackArmor Engineered Carbon/PEEK (search), announced that the U.S. Food and Drug Administration (FDA) has cleared the CMORE CT System (search) for use in the cervicothoracic spine (search). The approval represents a significant advancement in spinal implant technology, introducing the world's first nonmetallic and radiolucent spinal implants for posterior stabilization of the upper spine.
Revolutionary Material Technology
The CMORE CT System (search) utilizes BlackArmor Engineered Carbon/PEEK (search), a combination composite material featuring continuous, high-strength carbon fibers and polyether ether ketone (PEEK), manufactured through a proprietary process developed by icotec (search). The resulting implant component exhibits an interwoven 3D fiber architecture that provides radiolucent properties across all diagnostic imaging modalities, including MRI, CT, and X-ray.
This radiolucent characteristic addresses a critical limitation in traditional metallic spinal implants, which can create imaging artifacts that obscure postoperative assessment and complicate treatment planning, particularly in oncological applications.
Comprehensive System Design
The CMORE CT System (search) comprises a full portfolio of components designed to accommodate anatomical and pathological variations in patients. The system includes polyaxial screws, straight and precontoured rods, and both axial and parallel connectors, providing surgeons with the versatility needed for complex cervicothoracic procedures.
"The FDA clearance of the CMORE CT System (search) marks another milestone in our commitment to advancing care for patients with spinal tumors (search), infections, and complex pathologies," said Christoph Eigenmann, CEO of icotec (search) Medical, U.S. "By expanding our BlackArmor technology to the posterior cervical spine, we're giving surgeons and radiation oncologists a new level of visibility and confidence in their postoperative and oncological decision-making."
Clinical Applications and Benefits
The system enables a full spectrum of treatment modalities in adjuvant tumor therapy while enhancing postoperative imaging diagnostics in the cervicothoracic spine (search). This capability is particularly valuable for patients requiring ongoing monitoring and treatment adjustments, as the radiolucent properties allow for clear visualization of anatomical structures and potential complications without interference from implant artifacts.
The technology addresses specific challenges in treating spinal tumors (search), infections, and complex pathologies where precise imaging is crucial for treatment success and patient monitoring.
Market Position and Future Outlook
icotec (search) positions itself as the leading company for spinal tumor treatment with its new generation of high-tech implants. The company's comprehensive product portfolio has received both FDA and CE clearance and is supported by numerous key opinion leaders and spine surgery centers worldwide.
The upcoming commercial launch of the CMORE CT System (search) in the United States will expand icotec (search)'s portfolio of BlackArmor Engineered Carbon/PEEK (search) implants, all designed for artifact-free imaging and seamless integration across the spine. This expansion represents the company's continued commitment to advancing spinal implantation technology and improving patient outcomes through innovative material science and engineering solutions.